Nicorette, Axid switches scheduled for Sept. 28 NDAC meeting.
This article was originally published in The Tan Sheet
Executive Summary
NICORETTE AND AXID OTC SWITCHES SCHEDULED FOR NDAC REVIEW on Sept. 28. In the morning and early afternoon, FDA's Nonprescription Drug and Drug Abuse Advisory Committees will discuss SmithKline Beecham's Rx-to-OTC switch application for Nicorette nicotine chewing gum 2 mg and 4 mg (NDAs 20-066 and 18-612).